Mild Hypofractionation using Proton Therapy or IMRT for Low- and Intermediate-Risk Prostate Cancer

Recruiting
99 years or below
All
Phase
N/A
1 Location
Brief description of study
This is a study to first establish feasibility of the study and then to register the treatment data of adult patients with a diagnosis of low or intermediate risk of prostate cancer presenting for definitive radiation treatment with either proton radiotherapy or IMRT. We propose to employ a hypofractionated strategy with our image guided treatment to further improve cancer control and decrease toxicity.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: prostate cancer
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 810313